{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:43:03Z","timestamp":1776753783049,"version":"3.51.2"},"reference-count":44,"publisher":"BMJ","issue":"24","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To inform a clinical practice guideline (BMJ Rapid Recommendations) considering sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for treatment of adults with type 2 diabetes, we summarised the available evidence regarding the performance of validated risk models on cardiovascular and kidney outcomes in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically searched bibliographic databases in January 2020 to identify observational studies evaluating risk models for all-cause and cardiovascular mortality, heart failure (HF) hospitalisations, end-stage kidney disease (ESKD), myocardial infarction (MI) and ischaemic stroke in ambulatory adults with type 2 diabetes. Using a random effects model, we pooled discrimination measures for each model and outcome, separately, and descriptively summarised calibration plots, when available. We used the Prediction Model Risk of Bias Assessment Tool to assess risk of bias of each included study and the Grading of Recommendations, Assessment, Development, and Evaluation approach to evaluate our certainty in the evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 22 589 publications identified, 15 observational studies reporting on seven risk models proved eligible. Among the seven models with &gt;1 validation cohort, the Risk Equations for Complications of Type 2 Diabetes (RECODe) had the best calibration in primary studies and the highest pooled discrimination measures for the following outcomes: all-cause mortality (C-statistics 0.75, 95% CI 0.70 to 0.80; high certainty), cardiovascular mortality (0.79, 95% CI 0.75 to 0.84; low certainty), ESKD (0.73, 95% CI 0.52 to 0.94; low certainty), MI (0.72, 95% CI 0.69 to 0.74; moderate certainty) and stroke (0.71, 95% CI 0.68 to 0.74; moderate certainty). This model does not, however, predict risk of HF hospitalisations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Of available risk models, RECODe proved to have satisfactory calibration in primary validation studies and acceptable discrimination superior to other models, though with high risk of bias in most primary studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>CRD42020168351.<\/jats:p><\/jats:sec>","DOI":"10.1136\/heartjnl-2021-319243","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T17:30:22Z","timestamp":1617903022000},"page":"1962-1973","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses"],"prefix":"10.1136","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-8950","authenticated-orcid":false,"given":"Tayler A","family":"Buchan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Suk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang Zhou","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina Abril","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-5144","authenticated-orcid":false,"given":"Qiukui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-0287","authenticated-orcid":false,"given":"Sheyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem A","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Olav","family":"Vandvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-1812","authenticated-orcid":false,"given":"Farid","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"2022042504050860000_107.24.1962.1","unstructured":"International Diabetes Federation . Internaltional diabetes Federation. 9th ed. Brussels, Belgium, 2019."},{"key":"2022042504050860000_107.24.1962.2","unstructured":"Prevention CfDCa . National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2020."},{"key":"2022042504050860000_107.24.1962.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"2022042504050860000_107.24.1962.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"2022042504050860000_107.24.1962.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"2022042504050860000_107.24.1962.6"},{"key":"2022042504050860000_107.24.1962.7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-5-8"},{"key":"2022042504050860000_107.24.1962.8","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1377"},{"key":"2022042504050860000_107.24.1962.9","unstructured":"Siemieniuk R , Vandvik P , Alonso-Coello P . Hartung-Knapp-Sidik-Jonkman confidence intervals can be bizarrely narrow when heterogeneity is very low 2016."},{"key":"2022042504050860000_107.24.1962.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6460"},{"key":"2022042504050860000_107.24.1962.11","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X0800800102"},{"key":"2022042504050860000_107.24.1962.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2022042504050860000_107.24.1962.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.12.023"},{"key":"2022042504050860000_107.24.1962.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1548"},{"key":"2022042504050860000_107.24.1962.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1159"},{"key":"2022042504050860000_107.24.1962.16","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-2002"},{"key":"2022042504050860000_107.24.1962.17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022042504050860000_107.24.1962.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.042685"},{"key":"2022042504050860000_107.24.1962.19","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1736"},{"key":"2022042504050860000_107.24.1962.20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12751-3","article-title":"A Point-based mortality prediction system for older adults with diabetes","volume":"7","author":"Chang","year":"2017","journal-title":"Sci Rep"},{"key":"2022042504050860000_107.24.1962.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1358"},{"key":"2022042504050860000_107.24.1962.22","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1210\/jc.2019-00215","article-title":"Estimation of mortality risk in type 2 diabetic patients (enforce): an inexpensive and parsimonious prediction model","volume":"104","author":"Copetti","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022042504050860000_107.24.1962.23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/j.1326-5377.2009.tb02343.x","article-title":"Comparison of the Framingham and United Kingdom prospective diabetes study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle diabetes study","volume":"190","author":"Davis","year":"2009","journal-title":"Med J Aust"},{"key":"2022042504050860000_107.24.1962.24","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1906"},{"key":"2022042504050860000_107.24.1962.25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003587","article-title":"An aggregate biomarker risk score predicts high risk of near-term myocardial infarction and death: findings from Bari 2D (bypass angioplasty revascularization investigation 2 diabetes)","volume":"6","author":"Ghasemzadeh","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022042504050860000_107.24.1962.26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/clc.22991","article-title":"Use of the progression of adapted diabetes complications severity index to predict acute coronary syndrome, ischemic stroke, and mortality in Asian patients with type 2 diabetes mellitus: a nationwide cohort investigation","volume":"41","author":"Hu","year":"2018","journal-title":"Clin Cardiol"},{"key":"2022042504050860000_107.24.1962.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062650","article-title":"Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data","volume":"8","author":"Ahmad Kiadaliri","year":"2013","journal-title":"PLoS One"},{"key":"2022042504050860000_107.24.1962.28","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000020091.07144.C7"},{"key":"2022042504050860000_107.24.1962.29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s40273-019-00822-4","article-title":"Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort","volume":"37","author":"Laxy","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"2022042504050860000_107.24.1962.30","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00125-013-2933-x","article-title":"Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS outcomes model in the Casale Monferrato survey, Italy","volume":"56","author":"Pagano","year":"2013","journal-title":"Diabetologia"},{"key":"2022042504050860000_107.24.1962.31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13098-015-0055-y","article-title":"Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: diabetes heart study","volume":"7","author":"Raffield","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"2022042504050860000_107.24.1962.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.02.015"},{"key":"2022042504050860000_107.24.1962.33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40273-018-0662-1","article-title":"Novel risk engine for diabetes progression and mortality in USA: building, relating, assessing, and validating outcomes (BRAVO)","volume":"36","author":"Shao","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"2022042504050860000_107.24.1962.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.10.011"},{"key":"2022042504050860000_107.24.1962.35","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0958"},{"key":"2022042504050860000_107.24.1962.36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jval.2013.06.001","article-title":"Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort","volume":"16","author":"Tao","year":"2013","journal-title":"Value Health"},{"key":"2022042504050860000_107.24.1962.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0745"},{"key":"2022042504050860000_107.24.1962.38","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.87","article-title":"Prediction of morbidity and mortality in patients with type 2 diabetes","volume":"1","author":"Wells","year":"2013","journal-title":"PeerJ"},{"key":"2022042504050860000_107.24.1962.39","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-7-9"},{"key":"2022042504050860000_107.24.1962.40","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1273"},{"key":"2022042504050860000_107.24.1962.41","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.5.451"},{"key":"2022042504050860000_107.24.1962.42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1010539519873487","article-title":"Assessing 10-year cardiovascular disease risk in Malaysians with type 2 diabetes mellitus","volume":"31","author":"Yew","year":"2019","journal-title":"Asia Pacific Journal of Public Health"},{"key":"2022042504050860000_107.24.1962.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0759-z","article-title":"Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data","volume":"17","author":"Young","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2022042504050860000_107.24.1962.44","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10321014"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2021-319243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T11:07:29Z","timestamp":1650884849000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2021-319243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":44,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,11,25]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/heartjnl-2021-319243"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2021-319243","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}